
    
      20 patients with newly diagnosed histopathologically confirmed glioblastoma (WHO Grade IV)
      after surgery will be enrolled in the study. All of the patients will receive conventional
      concurrent chemoradiation and adjuvant temozolomide plus bevacizumab begin > 3 weeks and â‰¤ 5
      weeks after surgery.
    
  